Items where authors include "Catlett, IM"

Article

Conaghan, PG orcid.org/0000-0002-3478-5665, Nowak, M, Du, S et al. (7 more authors) (2023) Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study. The Lancet Rheumatology, 5 (5). e263-e273. ISSN 2665-9913